Arginine Methylation: The Coming of Age.

Mol Cell 2017 Jan;65(1):8-24

Terry Fox Molecular Oncology Group and the Bloomfield Center for Research on Aging, Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital, Montréal, QC H3T 1E2, Canada; Departments of Oncology and Medicine, McGill University, Montréal, QC H2W 1S6, Canada. Electronic address:

Arginine methylation is a common post-translational modification functioning as an epigenetic regulator of transcription and playing key roles in pre-mRNA splicing, DNA damage signaling, mRNA translation, cell signaling, and cell fate decision. Recently, a wealth of studies using transgenic mouse models and selective PRMT inhibitors helped define physiological roles for protein arginine methyltransferases (PRMTs) linking them to diseases such as cancer and metabolic, neurodegenerative, and muscular disorders. This review describes the recent molecular advances that have been uncovered in normal and diseased mammalian cells.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molcel.2016.11.003DOI Listing
January 2017
5 Reads

Publication Analysis

Top Keywords

arginine methylation
8
prmt inhibitors
4
selective prmt
4
models selective
4
inhibitors helped
4
define physiological
4
roles protein
4
physiological roles
4
mouse models
4
helped define
4
wealth studies
4
cell signaling
4
translation cell
4
mrna translation
4
signaling cell
4
cell fate
4
protein arginine
4
decision wealth
4
fate decision
4
transgenic mouse
4

Similar Publications